Form 4: ANI Pharmaceuticals Executive Meredith Cook Sells 400 Shares
SEC Form 4
Meredith Cook, SR. VP, GENERAL COUNSEL & SEC. of ANI Pharmaceuticals, sold 400 shares of common stock on January 13, 2025, at a price of $53.92 per share.
Summary
- On January 13, 2025, Meredith Cook, SR. VP, GENERAL COUNSEL & SEC. of ANI Pharmaceuticals, sold 400 shares of common stock.
- The sale was executed at a price of $53.92 per share.
- Following the transaction, Cook directly owns 55,588 shares of ANI Pharmaceuticals.
- The sale was conducted under a Rule 10b5-1 trading plan adopted on September 17, 2024.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it's a standard disclosure of an insider transaction. The sale itself doesn't necessarily indicate a positive or negative outlook.
Industry Context
This is a routine disclosure of an insider transaction. It's common for executives to have pre-arranged trading plans to avoid accusations of trading on inside information.
Stakeholder Impact
- The sale of shares by an executive could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 09/17/2024 | Date of adoption of Rule 10b5-1 trading plan |
| 01/13/2025 | Date of transaction: Sale of 400 shares |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.